Unjha Formulations Surges to 52-Week High, Outperforms Sector by 5.25%

Unjha Formulations, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high on May 23, 2024. The stock has been performing well in the market, outperforming its sector by 5.25%.

According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for Unjha Formulations is 'Hold'. The stock has been on a consecutive gain for the past three days, with a 15.21% increase in returns during this period.

On May 23, the stock touched an intraday high of Rs 34.99, showing a 4.57% increase, while the intraday low was Rs 31.9, with a decrease of 4.66%. Unjha Formulations is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In the past year, Unjha Formulations has shown a remarkable performance with a 122.59% increase, while the Sensex has only seen a 19.85% growth. This showcases the company's strong performance and potential for growth in the pharmaceutical industry.

Unjha Formulations is a microcap company, but its recent stock performance and positive outlook make it a promising player in the market. With its consistent gains and outperformance in the sector, the company is definitely one to watch out for in the future.